Borosil Ltd · NSE:BOROLTD
Borosil — Q4 FY2021 Earnings Presentation
39 slides from Borosil's earnings presentation, May 29, 2021
Slide 1: Letter to stock exchanges: presentation on Q4 and FY21 performance
May 29, 2021 The DCS - CRD BSE Limited National Stock Exchange of India Ltd Corporate Relationship Department Exchange Plaza, C-1, Block G, 1st Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, P. J. Towers, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai – 400 001 Dear Sir / Mad
Slide 2: Borosil Limited - Investor Presentation Q4FY21
Borosil Limited - Investor Presentation Q4FY21 Borosil Investor presentation - Q4FY21 01
Slide 3: Safe harbour statement
Safe harbour statement “This investor presentation has been prepared by Borosil Limited (“Borosil” or “Company”) on a strictly Borosil Investor presentation - Q4FY21 02
Slide 4: About Borosil
About Borosil Brand with a years of Borosil 50+year legacy Market Leader- Microwavable Kitchenware in India (Consumer Products) Market Leader- Laboratory Glassware Borosil Investor presentation - Q4FY21 03
Slide 5: Vision
Vision To be the most customer-centric company in India Borosil Investor presentation - Q4FY21 04
Slide 6: Re-Imagining Consumer
Re-Imagining Consumer Glass Products Consumer Brands Company Company Occasional Use Daily Use (Dinnerware, (Microwavable) Storage, Appliances) - Single Brand Adding brands - - General Trade General Trade Modern Trade E-Commerce Borosil Investor presentation - Q4FY21 05
Slide 7: Three Brands
Three Brands Single Brand BOROSIL BOROSIL LabQuest Klasspack Lab Glassware Lab Glassware only Lab Instruments Pharma Packaging Domestic Business Domestic Business International Business Borosil Investor presentation - Q4FY21 06
Slide 8: Journey over last 8 years
Journey over last 8 years Sales CAGR: 20% CAGR: 29% 585 90 2020-21 2020-21 135 2012-13 12 2012-13 Borosil Investor presentation - Q4FY21
Slide 9: Financial Overview Q4FY21 (consolidated)
Financial Overview Q4FY21(consolidated) INR Crore Q4 FY20 Q4 FY21 Growth % Net Sales 141.76 184.06 29.8% EBITDA (3.12) 37.90 1315.1% EBITDA 12.88 37.90 194.2% (Before one-time items) PBT (13.71) 27.91 303.5% PAT (10.62) 18.44 273.6% Net Cash (Period end) 71.74 245.51 Borosil Investor presentation -
Slide 10: Financial Overview FY21 (consolidated)
Financial Overview FY21(consolidated) INR Crore FY20 FY21 Growth % Net Sales 635.85 584.77 (8.0)% EBITDA 87.39 99.13 13.4% EBITDA 103.39 102.74 (0.6)% (Before one-time items) PBT 43.58 61.24 40.5% PAT 35.32 42.36 19.9% Net Cash (Period end) 71.74 245.51 Borosil Investor presentation - Q4FY21 09
Slide 11: Capital Employed (Standalone)
Capital Employed (Standalone) INR Crore Consumerware Scientific Borosil FY20 FY21 FY20 FY21 FY20 FY21 Working Capital 170 115 58 56 44 102 Employed Working Capital 105 97 55 130 113 71 (Days of Sales) Operating Capital 311 223 142 103 453 327 Employed Goodwill * 59 59 Strategic Investments ** 67 67 N
Slide 12: Category wise sales (Consumerware)
Category wise sales (Consumerware) INR Crore Category Q4 FY20 Q4 FY21 Growth % FY20 FY21 Growth % Glassware 26.94 30.29 12.4% 158.87 104.45 (34.3)% Non Glassware 30.45 35.99 18.2% 120.70 139.29 15.4% Opalware 28.97 51.78 78.7% 154.47 141.05 (8.7)% Total Consumerware 86.36 118.06 36.7% 434.04 384.79
Slide 13: Category wise sales (Scientific)
Category wise sales (Scientific) INR Crore Category Q4 FY20 Q4 FY21 Growth % FY20 FY21 Growth % Laboratory Glassware 38.58 44.23 14.6% 142.05 126.52 (10.9)% Lab Instrumentation 4.71 5.81 23.4% 14.73 15.92 8.1% Pharma Packaging 12.11 15.96 31.8% 45.03 57.54 27.8% Total Scientific 55.40 66.00 19.1% 20
Slide 14: Cross category participation to derisk the business (Consumerware)
Cross category participation to derisk the business (Consumerware) INR Crore Category Q1 FY20 Q2 FY20 Q3 FY20 Q4 FY20 FY20 Glassware 35.86 51.11 44.95 26.94 158.87 Non Glassware 16.14 30.50 43.60 30.45 120.70 Opalware 27.37 46.59 51.55 28.97 154.47 Total Consumerware 79.38 128.20 140.10 86.36 434.04
Slide 15: Cross category participation to derisk the business (Scientific)
Cross category participation to derisk the business (Scientific) INR Crore Category Q1 FY20 Q2 FY20 Q3 FY20 Q4 FY20 FY20 Laboratory Glassware 36.45 32.49 34.53 38.58 142.05 Lab Instrumentation 3.00 3.02 4.02 4.71 14.73 Pharma Packaging 10.15 10.69 12.08 12.11 45.03 Total Scientific 49.60 46.20 50.62 5
Slide 16: Cost and margin ratios (consolidated business)
(consolidated business) % of Net Revenue Q4 FY20 Q4 FY21 FY20 FY21 Advertising & Sales 2.4% 2.9% 5.0% 4.0% Promotion (ASP) Personnel Costs 8.8% 11.7% 12.5% 14.4% EBITDA Margin 5.9% 17.4% 15.4% 16.0% (before one-time items) EBITDA Margin before 8.3% 20.3% 20.4% 20.0% ASP & one time items Borosil Inve
Slide 17: Consumer Division
Consumer Division Borosil Investor presentation - Q4FY21 16
Slide 18: Storage, Cooking & Serving needs of a modern kitchen
Storage, Cooking & Serving needs of a modern kitchen Cook Serve Store Cut, Chop, Cook, Bake, Grind, Mix Toast, Grill • Contemporary • • Everyday Use • • • • • Borosil Investor presentation - Q4FY21 17
Slide 19: Consumer Products
Consumer Products Market Growth % Glass Microwaveables 100 10% Tumblers 440 10% Storage 15% to 20% Opalware 500 20% 15% Domestic Appliances 9000 10% Note : Market size, growth & share are internal estimates Borosil Investor presentation - Q4FY21 18
Slide 20: Borosil - Ally of Progressive Homemaker
Borosil - Ally of Progressive Homemaker #Morning Preps, Chai, Breakfast, 6 AM Appliances Storage Cookware Dinnerware #Lunch 9 AM Husband, #Dinner Prep, Kids Evening Tea, 9 PM Dinner Serving Lunch Box Heat & Serve Wet storage 6 PM #Social meetings, hi tea, Travel, Workout Borosil Investor presentatio
Slide 21: Trade Partners
Trade Partners Borosil Investor presentation - Q4FY21 20
Slide 22: \~\T'IMES
www.ifbappliances.com ..····:· ••••• ............ • •• BOSCH \~\T'IMES ~ WALLACE PHARMACEUTICAlS PVT. LTD. lnduslnd Bank INTERNET ALKEN ~OCKHAI?DT LiFE W iNS qtenma~k A dose of life sPHARMA A new way for a new world Borosil Investor presentation - Q4FY21 21
Slide 23: Growth Pillars
Growth Pillars Domestic Appliances Borosil Investor presentation - Q4FY21 22
Slide 24: Category gaining salience
Category gaining salience Larah FY21 revenue INR 141.05 cr Borosil Investor presentation - Q4FY21 23
Slide 25: Storage Range
Storage Range Thoughtful Products creating a new pillar of growth Borosil Investor presentation - Q4FY21 24
Slide 26: Medium-Term Thrust Areas
Medium-Term Thrust Areas 20 Borosil Investor presentation - Q4FY21 25
Slide 27: Scientific Division: Borosil
BOROSII: 1 I . • • ." Borosil Investor presentation - Q4FY21 26
Slide 28: Lab Instrumentation
Lab Instrumentation Magnetic Stirrer Glass vials Burettes Block Digester Glass ampoules Pipettes Multi-Tube Vortexer Liquid handling systems Borosil Investor presentation - Q4FY21 27
Slide 29: Lab Glassware, Lab Instrumentation and Pharma Packaging markets
Lab Glassware Lab Pharma Packaging Lab Glassware India Exports Instrumentation (Vials & Ampoules) Market Size (INR Cr) 235 4000 150 235 Est. Market Growth ~8-10% ~0-2% ~8-10% ~10-12% Customers Pharma R&D & QC, Pharma R&D & QC Pharma R&D & QC, Pharma cos Government Labs, Government Labs, Food & Soil
Slide 30: Some key Customers
Some key Customers Borosil Investor presentation - Q4FY21 29
Slide 31: Growth Pillars
Growth Pillars International Core laboratory Become 2nd credible Borosil Investor presentation - Q4FY21 30
Slide 32: Medium-Term Thrust Areas
Medium-Term Thrust Areas 10 Maintain EBITDA Margins Borosil Investor presentation - Q4FY21 31
Slide 33: Laboratory Glassware
Laboratory Glassware -- Meeting wide product range need of customer -- -- - Single supplier convenient for laboratory for multiple critical yet low ticket SKUs - - Not easily replicable by competition Quick & on-time delivery of SKU range - Investment in inventory, 6 warehouses & dealer network - We
Slide 34: Primary Packaging for Pharma
Primary Packaging for Pharma Glass Ampoules & Tubular Glass Vials for packaging pharmaceutical products Complements Borosil’s analytical vials range (used in the lab) Provides Borosil’s Pharmaceutical Customers credible 2nd alternative for their packaging needs more entrants COVID 19 opening many ma
Slide 35: Key Enablers & Capabilities in Consumer business
Key Enablers & Capabilities in Consumer business Borosil Investor presentation - Q4FY21 34
Slide 36: Shreevar Kheruka, Chairman
Shreevar Kheruka Chairman Borosil Investor presentation - Q4FY21 35
Slide 37: Shareholding pattern
11,41,91,467 2.1% 0.3% Other 1369812D:IN BOROLTD 543212 27.2% Others INR 1927 Cr Promoters as on - 31 Mar 2021 : Borosil Investor presentation - Q4FY21 36
Slide 38: Investor Relations
Borosil Limited 1101, Crescenzo,G-Block, Opposite MCA Club, Bandra Kurla Complex Bandra (East), Mumbai - 400 051. India www.borosil.com www.myborosil.com Investor Relations: (anand.sultania@borosil.com) Borosil Investor presentation - Q4FY21 37
Slide 39: borosil.com myborosil.com
borosi/.com I myborosil.com -- -- -- r - " ' ' / -- -- l - " -- - l - - l -- - -- r -- " - - Borosil Investor presentation - Q4FY21 38